Abiraterone Acetate Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)
Condition:   Prostatic Neoplasms Interventions:   Drug: EPI-7386;   Drug: Abiraterone Acetate;   Drug: Prednisone or Prednisolone;   Drug: Apalutamide Sponsor:   Janssen Research & Development, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2022 Category: Research Source Type: clinical trials

TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
Conditions:   Prostatic Neoplasms, Castration-Resistant;   Drug Therapy, Combination Intervention:   Drug: TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone Sponsor:   West China Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2021 Category: Research Source Type: clinical trials